Thu, Oct 23, 2014, 1:42 PM EDT - U.S. Markets close in 2 hrs 18 mins

Recent

% | $
Quotes you view appear here for quick access.

Johnson & Johnson Message Board

  • Bandit94536 Bandit94536 Dec 4, 1997 3:58 PM Flag

    Coronary stent patents

    (1) Will JNJ/Cordis win the war in defending their coronary stent patents?

    (2) If they fail in their effort to keep better stents; i.e., from Guidant, AVE, etc., how will they defend their installed base, without resorting to a pricing war? Any ideas? My assumption that there are much better stents available is based on Cordis' low market share in Europe, Japan, etc. My concern for a pricing war is based on how Cordis has attempted to protect their installed base in these markets.

    (3) Assuming Guidant, AVE, and Medtronic's B stent become available, does anyone have an opinion as to an eventual average sales price for stents. Despite PTCA balloon prices haven fallen by 60% or more, once the industry began competing on price, the
    analysts seem reluctant to project deep price declines for stents? It gives me no comfort knowing that the all the analysts were "asleep at the wheel" with regard to PTCA balloons, but I am missing something with regard to stents? Or, is this another case of the anlaysts propping up the price of stocks. Any opinions?

 
JNJ
102.74+1.52(+1.51%)1:41 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.